Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth strategies at a meeting with the investment community May 1.

The ScottCare Corp. announced it will highlight Ambucor, the company’s employable labor service division for CIED monitoring, at the 2015 Heart Rhythm Society Scientific Sessions in Boston, May 13-16.


As the use of point-of-care (POC) ultrasound continues to expand throughout hospitals and clinics, the ECRI Institute has released a new guide to the modality for practitioners. The document explains the difference between POC and traditional ultrasound, the different types of POC ultrasound units and the numerous applications for the technology.



While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the heart known as the epicardium that could help explain the fish’s remarkable ability to regrow cardiac tissue.


Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora Semicompliant Balloon Dilatation Catheter. Euphora is a pre-dilatation therapy used during a stent implantation to reopen a narrowed coronary artery caused by plaque buildup.

Pie Medical Imaging announces its new release of 3mensio Structural Heart, dedicated to planning of structural heart interventions. This new release contains an optimized Mitral workflow and a new Septal Crossing workflow for planning of mitral valve procedures to determine the appropriate access route based on computed tomography (CT) images. These new innovations will be shown at the EuroPCR in Paris, May 19- 22.


Physicians and staff working in cath labs are constantly exposed to direct X-ray beams and scatter radiation. Traditionally cath lab staff wear radiation badges to record exposure, but these only provide historical data, long after the exposures have taken place. To be meaningful and change habits to reduce exposure, some labs have adopted real-time dose recording systems, which all staff to see the doses they are receiving so they can literally take a step back to reduce their dose. 



Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai. The study is published in the April 29 edition of Nature Communications.


Subscribe Now